Origin, maturation and antigen presenting function of dendritic cells.

[1]  Francesca Granucci,et al.  Maturation Stages of Mouse Dendritic Cells in Growth Factor–dependent Long-Term Cultures , 1997, The Journal of experimental medicine.

[2]  Li Wu,et al.  Dendritic Cell Development in Culture from Thymic Precursor Cells in the Absence of Granulocyte/Macrophage Colony-stimulating Factor , 1996, The Journal of experimental medicine.

[3]  R. Testi,et al.  Ceramide Inhibits Antigen Uptake and Presentation by Dendritic Cells , 1996, The Journal of experimental medicine.

[4]  J. Banchereau,et al.  Dendritic cells capable of stimulating T cells in germinal centres , 1996, Nature.

[5]  E. Maraskovsky,et al.  Dramatic increase in the numbers of functionally mature dendritic cells in Flt3 ligand-treated mice: multiple dendritic cell subpopulations identified , 1996, The Journal of experimental medicine.

[6]  R. Steinman,et al.  Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. , 1996, Journal of immunological methods.

[7]  E. Gilboa,et al.  Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo , 1996, The Journal of experimental medicine.

[8]  S. H. van der Burg,et al.  Peptide‐pulsed dendritic cells induce tumoricidal cytotoxic T lymphocytes from healthy donors against stably HLA‐A*0201‐binding peptides from the Melan‐A/MART‐1 self antigen , 1996, European journal of immunology.

[9]  A. Lanzavecchia,et al.  Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-T help via APC activation , 1996, The Journal of experimental medicine.

[10]  C. Ruedl,et al.  Phenotypic and functional characterization of CD11c+ dendritic cell population in mouse Peyer's patches , 1996, European journal of immunology.

[11]  J. Banchereau,et al.  CD34+ hematopoietic progenitors from human cord blood differentiate along two independent dendritic cell pathways in response to GM-CSF+TNF alpha , 1996, The Journal of experimental medicine.

[12]  G. Schuler,et al.  High level IL-12 production by murine dendritic cells: upregulation via MHC class II and CD40 molecules and downregulation by IL-4 and IL-10 [published erratum appears in J Exp Med 1996 Oct 1;184(4):following 1590] , 1996, The Journal of experimental medicine.

[13]  G. Trinchieri,et al.  Mechanism of Suppression of Cell-Mediated Immunity by Measles Virus , 1996, Science.

[14]  Antonio Lanzavecchia,et al.  T Cell Activation Determined by T Cell Receptor Number and Tunable Thresholds , 1996, Science.

[15]  R. Steinman,et al.  Dendritic cells and macrophages can mature independently from a human bone marrow-derived, post-colony-forming unit intermediate. , 1996, Blood.

[16]  J. Peters,et al.  Dendritic cells: from ontogenetic orphans to myelomonocytic descendants. , 1996, Immunology today.

[17]  K. Shortman,et al.  Effects of excess GM-CSF levels on hematopoiesis and leukemia development in GM-CSF/max 41 double transgenic mice. , 1996, Leukemia.

[18]  Y. Uehara,et al.  A life stage of particle-laden rat dendritic cells in vivo: their terminal division, active phagocytosis, and translocation from the liver to the draining lymph , 1996, The Journal of experimental medicine.

[19]  J. Austyn.  New insights into the mobilization and phagocytic activity of dendritic cells , 1996, The Journal of experimental medicine.

[20]  K. Shortman,et al.  A subclass of dendritic cells kills CD4 T cells via Fas/Fas-ligand- induced apoptosis , 1996, The Journal of experimental medicine.

[21]  Liangji Zhou,et al.  CD14+ blood monocytes can differentiate into functionally mature CD83+ dendritic cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[22]  K. Rock.  A new foreign policy: MHC class I molecules monitor the outside world. , 1996, Immunology today.

[23]  L. Zitvogel,et al.  Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokines , 1996, The Journal of experimental medicine.

[24]  M. Colombo,et al.  Murine dendritic cells loaded in vitro with soluble protein prime cytotoxic T lymphocytes against tumor antigen in vivo , 1996, The Journal of experimental medicine.

[25]  W. Strober,et al.  Distinct populations of dendritic cells are present in the subepithelial dome and T cell regions of the murine Peyer's patch , 1996, The Journal of experimental medicine.

[26]  K. Inaba,et al.  Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity , 1996, The Journal of experimental medicine.

[27]  J. Mayordomo,et al.  Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity , 1996, The Journal of experimental medicine.

[28]  L. Zitvogel,et al.  Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity , 1995, Nature Medicine.

[29]  A. Anichini,et al.  Massive ex vivo generation of functional dendritic cells from mobilized CD34+ blood progenitors for anticancer therapy. , 1995, Experimental hematology.

[30]  N. Shastri,et al.  Class I MHC presentation of exogenous soluble antigen via macropinocytosis in bone marrow macrophages. , 1995, Immunity.

[31]  P. Allavena,et al.  Migration of dendritic cells in response to formyl peptides, C5a, and a distinct set of chemokines. , 1995, Journal of immunology.

[32]  A. Galy,et al.  Human T, B, natural killer, and dendritic cells arise from a common bone marrow progenitor cell subset. , 1995, Immunity.

[33]  M. Moser,et al.  Glucocorticoids down‐regulate dendritic cell function in vitro and in vivo , 1995, European journal of immunology.

[34]  M. Bevan,et al.  Antigen presentation to cytotoxic T lymphocytes in vivo , 1995, The Journal of experimental medicine.

[35]  R. Germain,et al.  Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis , 1995, The Journal of experimental medicine.

[36]  R. Steinman,et al.  The endocytic activity of dendritic cells , 1995, The Journal of experimental medicine.

[37]  C Danieli,et al.  Dendritic cells use macropinocytosis and the mannose receptor to concentrate macromolecules in the major histocompatibility complex class II compartment: downregulation by cytokines and bacterial products , 1995, The Journal of experimental medicine.

[38]  K. Rock,et al.  Targeting antigen into the phagocytic pathway in vivo induces protective tumour immunity , 1995, Nature Medicine.

[39]  G. Pauli,et al.  Spontaneous apoptosis of dendritic cells is efficiently inhibited by TRAP (CD40‐ligand) and TNF‐α, but strongly enhanced by interleukin‐10 , 1995, European journal of immunology.

[40]  P. Allavena,et al.  IL-13 supports differentiation of dendritic cells from circulating precursors in concert with GM-CSF. , 1995, European cytokine network.

[41]  Eric O Long,et al.  Antigen presentation mediated by recycling of surface HLA-DR molecules , 1995, Nature.

[42]  J. Kinet,et al.  The high affinity IgE receptor (Fc epsilon RI) mediates IgE-dependent allergen presentation. , 1995, Journal of immunology.

[43]  P. Morris,et al.  Dendritic cell loss from nonlymphoid tissues after systemic administration of lipopolysaccharide, tumor necrosis factor, and interleukin 1 , 1995, The Journal of experimental medicine.

[44]  M. Moore,et al.  Expansion of immunostimulatory dendritic cells among the myeloid progeny of human CD34+ bone marrow precursors cultured with c-kit ligand, granulocyte-macrophage colony-stimulating factor, and TNF-alpha. , 1995, Journal of immunology.

[45]  G. Trinchieri,et al.  Dendritic cells produce IL-12 and direct the development of Th1 cells from naive CD4+ T cells. , 1995, Journal of immunology.

[46]  R. Steinman,et al.  The receptor DEC-205 expressed by dendritic cells and thymic epithelial cells is involved in antigen processing , 1995, Nature.

[47]  R. Kradin,et al.  The antigen-presenting activities of Ia+ dendritic cells shift dynamically from lung to lymph node after an airway challenge with soluble antigen , 1995, The Journal of experimental medicine.

[48]  M. Toribio,et al.  The Development of T and Non-t Cell Lineages from Cd34 § Human Thymic Precursors Can Be Traced by the Differential Expression of Cd44 Materials and Methods , 1995 .

[49]  M. Kovacsovics-Bankowski,et al.  A phagosome-to-cytosol pathway for exogenous antigens presented on MHC class I molecules , 1995, Science.

[50]  J. Banchereau,et al.  Activation of human dendritic cells through CD40 cross-linking , 1994, The Journal of experimental medicine.

[51]  J. Banchereau,et al.  Interleukin 10 inhibits T cell alloreaction induced by human dendritic cells. , 1994, International Immunology.

[52]  P. Holt,et al.  Rapid dendritic cell recruitment is a hallmark of the acute inflammatory response at mucosal surfaces , 1994, The Journal of experimental medicine.

[53]  F. Sallusto,et al.  Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha , 1994, The Journal of experimental medicine.

[54]  P. Herrlich,et al.  CD44 splice variants: metastases meet lymphocytes. , 1993, Immunology today.

[55]  C. Sousa,et al.  Phagocytosis of antigens by Langerhans cells in vitro , 1993, The Journal of experimental medicine.

[56]  P. Kalinski,et al.  Prostaglandin E2 differentially modulates cytokine secretion profiles of human T helper lymphocytes. , 1993, Journal of immunology.

[57]  Li Wu,et al.  Thymic dendritic cells and T cells develop simultaneously in the thymus from a common precursor population , 1993, Nature.

[58]  R. Steinman,et al.  Granulocytes, macrophages, and dendritic cells arise from a common major histocompatibility complex class II-negative progenitor in mouse bone marrow. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[59]  M. Amagai,et al.  Adhesion of epidermal Langerhans cells to keratinocytes mediated by E-cadherin , 1993, Nature.

[60]  R. Steinman,et al.  Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor , 1992, The Journal of experimental medicine.

[61]  J. Banchereau,et al.  GM-CSF and TNF-α cooperate in the generation of dendritic Langerhans cells , 1992, Nature.

[62]  J. Ring,et al.  Human epidermal Langerhans cells express the high affinity receptor for immunoglobulin E (Fc epsilon RI) , 1992, The Journal of experimental medicine.

[63]  R. Steinman,et al.  Identification of proliferating dendritic cell precursors in mouse blood , 1992, The Journal of experimental medicine.

[64]  P. Stahl.  The mannose receptor and other macrophage lectins , 1992, Current Biology.

[65]  I. Kimber,et al.  Dermal tumour necrosis factor-alpha induces dendritic cell migration to draining lymph nodes, and possibly provides one stimulus for Langerhans' cell migration. , 1992, Immunology.

[66]  G. Schuler,et al.  Class II major histocompatibility complex molecules of murine dendritic cells: synthesis, sialylation of invariant chain, and antigen processing capacity are down-regulated upon culture. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[67]  R. Steinman,et al.  Antigen processing by epidermal Langerhans cells correlates with the level of biosynthesis of major histocompatibility complex class II molecules and expression of invariant chain , 1990, The Journal of experimental medicine.

[68]  G. Schuler,et al.  Disappearance of certain acidic organelles (endosomes and Langerhans cell granules) accompanies loss of antigen processing capacity upon culture of epidermal Langerhans cells , 1990, The Journal of experimental medicine.

[69]  J. Sprent,et al.  Antigen‐presenting Cells for CD8+ T Cells , 1990, Immunological reviews.

[70]  Timothy A. Springer,et al.  Adhesion receptors of the immune system , 1990, Nature.

[71]  J. Kraehenbuhl,et al.  Minireview Gateways for Mucosal Infection and Immunization , 1996 .

[72]  G. Schuler,et al.  Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. , 1997, Advances in experimental medicine and biology.

[73]  J. Banchereau,et al.  GM-CSF and TNF-alpha cooperate in the generation of dendritic Langerhans cells. , 1992, Nature.

[74]  R. Steinman,et al.  The dendritic cell system and its role in immunogenicity. , 1991, Annual review of immunology.

[75]  C. Bruijnzeel-Koomen,et al.  IgE: an immunoglobulin specialized in antigen capture? , 1990, Immunology today.